SAGENOME is a company that provides clients with a vision & understanding of their unique genetic profile and its implication for better wellness. The field of health genomics has matured in the past two decades and is beginning to deliver genomic-based interventions for health and health care. Every human being will have huge amounts of genetic variation that creates the unique individuality seen in a person. It has now been proved beyond doubt that this unique grouping combination of individual distinct changes has a substantial impact on susceptibility to disease, health, and wellness traits of an individual. SAGENOME offers a state-of-the-art capacity to analyze genetic variations of customers and filter them through precise scientific data analysis to provide robust, accurate, and meaningful results of genetic predispositions. These DNA and related health tests will provide significant information about important aspects of your genetic health. Examples include genetic markers for clinical practice including cancer management (tumor markers), genetic health risks including susceptibility to cancer, heart disease & diabetes; wellness & health traits, personalized nutrition & dietary factors; fitness; skin and hair care; cellular aging; allergy, sensitivity and infertility management. 

SAGENOME Private Limited is a registered start-up industry, under the Department for Promotion of Industry & Internal Trade (DPIIT), Ministry of Commerce and Industry, Government of India. Our investigations and diagnostic services are branded on the propriety platform OhMyGene which generates novel options for people to make the best decisions possible to understand genetic risk. Simply said, OhMyGene promises people the capacity to know their DNA to manage wellness. We use this advanced genome science to enable precision medicine delivery, and disease treatment and provide disease prevention and wellness management strategies. SAGENOME’s Scientific Operations (SciOps) uses the state-of-the-art infrastructure for high-end genomic analysis. The Genome Reference Analysis Team (GRAT) leads big data analysis using artificial intelligence, machine learning, and disease annotation.


What We Do?

We integrate Genomics, Artificial Intelligence and Machine Learning to predict health and wellness. Our portfolio includes:
  • Personalized Genomic Tests For wellness
  • Clinical Genomic Tests
  • Genomics for Preventive Health Care
  • Molecular Diagnostics & Precision Medicine
  • Genomics R&D
  • Academic & Training Programs
  • Digital Franchisee & more…

The Center for Disease Genomics (CDG)

The SAGENOME Research Foundation promotes the Center for Disease Genomics (CDG), an independent academic and research facility that serves as a multi-institutional hub for the application of genomic sciences to better health and the environment.

The Center for Disease Genomics (CDG) leads the research and development division for SAGENOME. Leveraging the strengths of SAGENOME in whole-genome sequencing and genomic analysis, the mission of the Center for Disease Genomics is the advancement of genomic science and its application to drive novel biomedical discoveries. 

CDG’s areas of focus include the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, cardiovascular disease, neurodegenerative disease, and neuropsychiatric disease.

CDG will also do pioneering research into the application of genomics in Ayurveda and traditional medicine-based therapeutics. CDG will extend its expertise into Animal Genomics, Plant Genomics, and Sustainable Agriculture

CDG routine focus includes the following programs

  • Academic & Research Partnerships.
  • Sponsored Research Programs.
  • Post Graduate & Doctoral Programs In Disease Genomics Affiliated To International Universities.
  • Academic Training Programs
  • Internship Programs